UNSPSC 51171640: Picosulfate

This classification denotes a laxative with the molecular formula C18H13NO8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LR57574HN8, chemically known as 4,4-(2-pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) but generally known as picosulfate, which bears US NIH Compound Identifier 68654. European Medicines Agency schedules Picosulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10569MIG. The term PICOSULFATE is an International Non-Proprietary Name.

World Health Organization schedules picosulfate in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+].

UNSPSC 51171640 Picosulfate, a Commodity code, covers pharmaceutical products and testing materials that state and local governments procure for correctional, health, and welfare purposes. Recent solicitations show active demand for specimen-collection and drug-testing services, generic pharmaceuticals, and over-the-counter products supplied through authorized wholesale channels. State and local issuing bodies acquiring under this code include county correctional departments, state health agencies, and multistate cooperative purchasing alliances coordinating procurement across participating jurisdictions. The scope encompasses immunoassay screening with laboratory confirmation (LC/MS/MS or GC/MS), alternative testing methodologies such as oral fluid and hair testing, generic multi-source pharmaceuticals with specific National Drug Codes, and OTC products distributed through certified wholesalers with compliance to cGMP and DSCSA requirements.

Activity concentrates in Texas and Minnesota with interstate reach through cooperative purchasing vehicles. Collin County Community Supervision and Corrections Department issued RFP 2026-327 on July 9, 2026, due July 23, 2026, for offender specimen collection and drug testing services covering two collection sites in Plano and McKinney with an estimated contract value of $600,000 over two years plus three optional one-year renewals, requiring SAMHSA, Texas DPS, or CAP lab certification and per-test pricing models with screening, confirmation, or combined service options. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, due March 26, 2026, establishing multiple contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, effective July 1, 2026, with evaluation weighted 75 percent on price competitiveness and 25 percent across administrative compliance, EDI capability, and pricing format options. The Texas Health and Human Services Commission issued RFI HHS0017013 in late March 2026 to gather market intelligence on direct-to-manufacturer prescription programs outside traditional PBM and GPO channels, signaling future procurement development in therapeutic pharmacy initiatives.